Throughout his professional career in insurance and real estate, William Deyesso has held such esteemed roles as CEO and executive vice president. Also involved in multiple charities to varying degrees, William Deyesso supports the American Cancer Society. The ACS recently updated their recommendations regarding the human papilloma virus (HPV) vaccine to include males.
When the American Cancer Society began recommending the HPV vaccine in 2007, it was not yet approved for males, and there was not much evidence it was necessary. In light of more recent findings and new vaccines for the virus, the ACS decided to update their recommendations.
The American Cancer Society now recommends both boys and girls begin the HPV vaccination cycle around age 11, as the vaccine works best before a person becomes sexually active and is potentially exposed to the virus. If you miss those early vaccinations, the ACS says vaccinating between the ages of 13-26 is acceptable, but the vaccination will not be as effective in lowering your risk for cancer.
Transmitted through sexual contact, most unvaccinated adults will get HPV at some point in their life. In most cases, the virus goes away without raising any health concerns. In some cases, however, HPV can lead to various types of cancer, including cervical, throat, and vulva cancer.
The United States Centers for Disease Control warns that between 2008 and 2012, 29,000 cases of cancer could have potentially been avoided with the HPV vaccine. To learn more about the HPV vaccine and the American Cancer Society’s recommendations, visit cancer.org.
William Deyesso - Successful Boston Real Estate Developer and Insurance Executive